Berberine relieves insulin resistance via the cholinergic anti-inflammatory pathway in HepG2 cells

Abstract

Berberine (BBR) is an isoquinoline alkaloid extracted from Rhizoma coptidis and has been used for treating type 2 diabetes mellitus (T2DM) in China. The development of T2DM is often aβsociated with insulin resistance and impaired glucose uptake in peripheral tiβsues. In this study, we examined whether BBR attenuated glucose uptake dysfunction through the cholinergic anti-inflammatory pathway in HepG2 cells. Cellular glucose uptake, quantified by the 2-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)-amino]-2-deoxy-D-glucose (2-NBDG), was inhibited by 21% after HepG2 cells were incubated with insulin (10^-6 mol/L) for 36 h. Meanwhile, the expreβsion of alpha7 nicotinic acetylcholine receptor (α7nAChR) protein was reduced without the change of acetylcholinesterase (AChE) activity. The level of interleukin-6 (IL-6) in the culture supernatant, the ratio of phosphorylated I-kappa-B kinase-β (IKκβ) Ser181/IKKβ and the expression of nuclear factor-kappa B (NF-κB) p65 protein were also increased. However, the treatment with BBR enhanced the glucose uptake, increased the expression of α7nAChR protein and inhibited AChE activity. These changes were also accompanied with the decrease of the ratio of pIKKβ Ser181/IKKβ, NF-κB p65 expression and IL-6 level. Taken together, these results suggest that BBR could enhance glucose uptake, and relieve insulin resistance and inflammation in HepG2 cells. The mechanism may be related to the cholinergic anti-inflammatory pathway and the inhibition of AChE activity.

Keywords

berberine / glucose uptake / cholinergic anti-inflammatory pathway / inflammation / alpha7 nicotinic acetylcholine receptor

References

[1] AkashMSH, RehmanK, ChenS. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem, 2013, 114(3): 525-531 PMID: 22991242

[2] BergmanRN, FinegoodDT, KahnSE. The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest, 2002, 32(3): 35-45 PMID: 12028373

[3] KahnSE, HullRL, UtzschneiderKM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 2006, 444(7121): 840-846 PMID: 17167471

[4] SoumayaK. Molecular mechanisms of insulin resistance in diabetes. Adv Exp Med Biol, 2012, 771: 240-251 PMID: 23393683

[5] ShoelsonSE, LeeJ, GoldfineAB. Inflammation and insulin resistance. J Clin Invest, 2006, 116(7): 1793-1801 PMCID: 1483173 PMID: 16823477

[6] BulloM, Garcia-LordaP, MegiasI, et al. . Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res, 2003, 11(4): 525-531 PMID: 12690081

[7] KingGL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol, 2008, 79(8): 1527-1534 PMID: 18673007

[8] HirabaraSM, GorjãoR, VinoloMA, et al. . Molecular targets related to inflammation and insulin resistance and potential interventions. J Biomed Biotechnol, 2012, 2012: 1-16

[9] TraceyKJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest, 2007, 117(2): 289-296 PMCID: 1783813 PMID: 17273548

[10] Rosas-BallinaM, TraceyKJ. The neurology of the immune system: neural reflexes regulate immunity. Neuron, 2009, 64(1): 28-32 PMCID: 4533851 PMID: 19840545

[11] BencherifM, LippielloPM, LucasR, et al. . Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci, 2011, 68(6): 931-949 PMCID: 3678737 PMID: 20953658

[12] WangDW, ZhouRB, YaoYM. Role of cholinergic anti-inflammatory pathway in regulating host response and its interventional strategy for inflammatory diseases. Chin J Traumatol, 2009, 12(6): 355-364 PMID: 19930906

[13] van WesterlooDJ. The vagal immune reflex: a blessing from above. Wien Med Wochenschr, 2010, 160(5–6): 112-117 PMID: 20364413

[14] HoferS, EisenbachC, LukicIK, et al. . Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med, 2008, 36(2): 404-408 PMID: 18091537

[15] WangH, YuM, OchaniM, et al. . Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature, 2003, 421(6921): 384-388 PMID: 12508119

[16] MarreroMB, LucasR, SaletC, et al. . An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes. J Pharmacol Exp Ther, 2010, 332(1): 173-180 PMID: 19786623

[17] PazhangY, AhmadianS, MahmoudianM, et al. . Berberine-induced apoptosis via decreasing the survivin protein in K562 cell line. Med Oncol, 2011, 28(4): 1577-1583 PMID: 20517657

[18] ShirwaikarA, ShirwaikarA, RajendranK, et al. . In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine. Biol Pharm Bull, 2006, 29(9): 1906-1910 PMID: 16946507

[19] LiY, WangP, ZhuangY, et al. . Activation of AMPK by berberine promotes adiponectin multimerization in 3T3-L1 adipocytes. FEBS Letters, 2011, 585(12): 1735-1740 PMID: 21536037

[20] YiP, LuFE, XuLJ, et al. . Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKbeta. World J Gastroenterol, 2008, 14(6): 876-883 PMCID: 2687054 PMID: 18240344

[21] KimSH, ShinEJ, KimED, et al. . Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes. Biol Pharm Bull, 2007, 30(11): 2120-2125 PMID: 17978486

[22] YinJ, GaoZ, LiuD, et al. . Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab, 2008, 294(1): E148-E156 PMCID: 2464622 PMID: 17971514

[23] ZhangH, WeiJ, XueR, et al. . Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism, 2010, 59(2): 285-292 PMID: 19800084

[24] YangJ, YinJ, GaoH, et al. . Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients. Evid Based Complement Alternat Med, 2012, 2012: 363845 PMCID: 3310165 PMID: 22474499

[25] KimDK, LeeKT, BaekNI, et al. . Acetylcholinesterase inhibitors from the aerial parts of Corydalis speciosa. Arch Pharm Res, 2004, 27(11): 1127-1131 PMID: 15595415

[26] ZhangWY, LeeJJ, KimY, et al. . Amelioration of insulin resistance by scopoletin in high-glucose-induced, insulin-resistant HepG2 cells. Horm Metab Res, 2010, 42(13): 930-935 PMID: 20886413

[27] RenstromF, BurenJ, SvenssonM, et al. . Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes. Metabolism, 2007, 56(2): 190-198 PMID: 17224332

[28] ZouC, WangY, ShenZ. 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J Biochem Bioph Meth, 2005, 64(3): 207-215

[29] ZhangS, XiaoQ, LeW. Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant a-synuclein. PLoS One, 2015, 10(3): e119928

[30] EllmanGL, CourtneyKD, AndresVJ, et al. . A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol, 1961, 7: 88-95 PMID: 13726518

[31] DelhaseM, HayakawaM, ChenY, et al. . Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science, 1999, 284(5412): 309-313 PMID: 10195894

[32] WangH, YuM, OchaniM, et al. . Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature, 2003, 421(6921): 384-388 PMID: 12508119

[33] JeongH W, HsuK C, LeeJ W, et al. . Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab, 2009, 296(4): E955-E964 PMID: 19208854

[34] WangC, TanZ, ZouX, et al. . Inhibiting effect of berberine hydrochloride on ache: a biological information and biological effect study. Acta Med Univ Sci Technol Huazhong (Chinese), 2014, 43(5): 561-563

[35] LykhmusO, VoytenkoL, KovalL, et al. . Alpha7 Nicotinic acetylcholine receptor-specific antibody induces inflammation and amyloid beta42 accumulation in the mouse brain to impair memory. PLoS one, 2015, 10(3): e122706

[36] WangH, YuM, OchaniM, et al. . Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature, 2003, 421(6921): 384-388 PMID: 12508119

[37] TraceyKJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest, 2007, 117(2): 289-296 PMCID: 1783813 PMID: 17273548

[38] YiL, LuoJF, XieBB, et al. . a7 nicotinic acetylcholine receptor is a novel mediator of sinomenine anti-inflammation effect in macrophages stimulated by lipopolysaccharide. Shock, 2015, 44(2): 188-195 PMID: 25895149

[39] LiZW, ChuW, HuY, et al. . The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med, 1999, 189(11): 1839-1845 PMCID: 2193082 PMID: 10359587

[40] TakPP, FiresteinGS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest, 2001, 107(1): 7-11 PMCID: 198552 PMID: 11134171